Search Results - "CENTO, V"

Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors by DI MAIO, V. C, CENTO, V, MIRABELLI, C, ARTESE, A, COSTA, G, ALCARO, S, PERNO, C. F, CECCHERINI-SILBERSTEIN, F

“…Because of the extreme genetic variability of hepatitis C virus (HCV), we analyzed the NS5B polymerase genetic variability in circulating HCV…”
Get full text

Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals by Armenia, D., Gagliardini, R., Alteri, C., Svicher, V., Cento, V., Borghi, V., Vergori, A., Cicalini, S., Forbici, F., Fabeni, L., Bertoli, A., Brugneti, M., Gennari, W., Malagnino, V., Andreoni, M., Mussini, C., Antinori, A., Perno, C.F., Santoro, M.M., Ceccherini-Silberstein, F.

“…•In the last decade, resistance in HIV-DNA was 35% in Italy.•Resistance in HIV-DNA was stable over the period 2010-2021.•Complex treatment history was…”
Get full text

Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life by Cento, V., Barbaliscia, S., Lenci, I., Ruggiero, T., Magni, C.F., Paolucci, S., Babudieri, S., Siciliano, M., Pasquazzi, C., Ciancio, A., Perno, C.F., Ceccherini-Silberstein, F., Micheli, V., Troshina, Y., Biliotti, E., Milana, M., Melis, M., Teti, E., Lambiase, L., Menzaghi, B., Nicolini, L.A., Marenco, S., Di Maio, V.C., Aragri, M., Pecchioli, A., Bertoli, A., Sarrecchia, C., Macera, M., Coppola, N., Puoti, M., Romagnoli, D., Pellicelli, A., Bonora, S., Novati, S., Baldanti, F., Ghisetti, V., Andreoni, M., Taliani, G., Rizzardini, G., Angelico, M.

“…First-generation protease-inhibitors (PIs) have suboptimal efficacy in GT-1 patients with advanced liver disease, and patients experiencing treatment failure…”
Get full text

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon by Fokam, J., Salpini, R., Santoro, M. M., Cento, V., D’Arrigo, R., Gori, C., Perno, C. F., Colizzi, V., Nanfack, A., Gwom, L. C., Cappelli, G., Takou, D.

“…Most commercial HIV-1 genotyping assays are hampered by high cost in resource-limited settings. Moreover, their performance might be influenced over time by…”
Get full text

Failure to First-Line Direct Antiviral (DAA) Treatment of HCV Infection in an Italian Real-Life Urban Setting by Di Paolo, D, Rossi, P, Lenci, I, Milana, M, Masetti, C, Santopaolo, F, Lionetti, R, D’Offizi, G, Pellicelli, A, Fondacaro, L, Siciliano, M, Tortora, A, Chiesara, F, Moretti, A, Ceccherini-Silberstain, F, Cento, V, Perno, C.F, Angelico, M

Get full text

Different Prevalence of HCV Resistance and HCV RNA Quantification Within Tumoral and Non Tumoral Liver Tissues in HCC/Transplanted Patients by Sorbo, M.C, Antonucci, F.P, Manuelli, M, Lenci, I, Sforza, D, Carioti, L, Bellocchi, M.C, Cento, V, Di Paolo, D, De Leonardis, F, Milana, M, Manzia, T, Tisone, G, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

P0912 : Early-phase HCV kinetics and role of pre-existing resistance in cirrhotic or interferon-insensitive patients on daclatasvir plus asunaprevir by Cento, V, Calvaruso, V, Marenco, S, Alfieri, R, Aragri, M, Antonucci, F.P, Di Maio, V.C, Petta, S, Mazzola, A, Milanesi, L, Picciotto, A, Ceccherini-Silberstein, F, Craxì, A, Perno, C.F

Get full text

Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice by Salpini, R., Alteri, C., Cento, V., Pollicita, M., Micheli, V., Gubertini, G., De Sanctis, G.M., Visca, M., Romano, S., Sarrecchia, C., Andreoni, M., Angelico, M., Parruti, G., Svicher, V., Perno, C.F.

“…While the selection of complex HBV drug‐resistance patterns on therapeutic failure can compromise the efficacy of anti‐HBV therapies, recent data show that…”
Get full text

The challenge of HCV-retreatment after DAA-failure: real-life experience advocates for caution by Cento, V, Barbaliscia, S, Di Maio, V.C, Masetti, C, Minichini, C, Magni, C.F, Micheli, V, Marenco, S, Nicolini, L.A, Bruzzone, B, Troshina, Y, Baiguera, C, Dentone, C, Calvaruso, V, Paolucci, S, Melis, M, Aragri, M, Bertoli, A, Lenci, I, Landonio, S, Schiavini, M, Sticchi, L, Ruggiero, T, Polilli, E, Messina, V, Pellicelli, A, Boglione, L, Cozzolongo, R, Biolato, M, Morisco, F, Siciliano, M, Parruti, G, Barbarini, G, Craxì, A, Babudieri, S, Puoti, M, Ciancio, A, Rizzardini, G, Coppola, N, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

Virological Failures to New Direct Acting Antivirals in a Real Life Setting May Require Unconventional Regimens for Re-Treatment by Di Maio, V.C, Cento, V, Di Paolo, D, Lenci, I, Aragri, M, Verucchi, G, Melis, M, Bertoli, A, Antonucci, F.P, Francioso, S, Pellicelli, A, Calvaruso, V, Pasquazzi, C, Romagnoli, D, Biolato, M, Vecchiet, J, Morisco, F, Merli, M, Gaeta, G.B, Brillanti, S, Donato, F, Puoti, M, Pisani, V, Paoloni, M, Babudieri, S, Craxì, A, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

Different prevalence of HCV resistance and HCV quantification within blood and liver samples (tumoral and non tumoral tissues) of HCC/transplanted patients by Sorbo, M.C, Antonucci, F.P, Manuelli, M, Lenci, I, Sforza, D, Carioti, L, Bellocchi, M.C, Cento, V, Di Paolo, D, De Leonardis, F, Milana, M, Manzia, T, Tisone, G, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

Treatment failure to first-line direct antiviral (DAA) in HCV-related advanced liver disease: An Italian real-life urban setting by Di Paolo, D, Rossi, P, Lenci, I, Milana, M, Masetti, C, Santopaolo, F, Lionetti, R, D’Offizi, G, Pellicelli, A, Fondacaro, L, Siciliano, M, Gerardi, V, Chiesara, F, Moretti, A, Ceccherini-Silberstein, F, Cento, V, Perno, C.F, Angelico, M

Get full text

Biphasic Kinetics of HCV-RNA Decay is Accompanied by an even Faster Aminotransferases Normalization in All-Daa Treated Cirrhotic Patients: A Different Scenario from Interferon-Based Therapies by Cento, V, Di Carlo, D, Nguyen, T.H.T, Biliotti, E, Pasquazzi, C, Gianserra, L, Di Paolo, D, Calvaruso, V, Teti, E, Cerrone, M, Romagnoli, D, Melis, M, Danieli, E, Menzaghi, B, Polilli, E, Siciliano, M, Nicolini, L.A, Di Biagio, A, Magni, C.F, Antonucci, F.P, Di Maio, V.C, Alfieri, R, Sarmati, L, Casalino, P, Bernardini, S, Micheli, V, Rizzardini, G, Villa, E, Parruti, G, Quirino, T, Puoti, M, Babudieri, S, Monforte, A. D’A, Andreoni, M, Craxì, A, Lenci, I, Angelico, M, Taliani, G, Guedj, J, Ceccherini-Silberstein, F, Perno, C.F

Get full text

Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs by Salpini, R., Svicher, V., Cento, V., Gori, C., Bertoli, A., Scopelliti, F., Micheli, V., Cappiello, T., Spanò, A., Rizzardini, G., De Sanctis, G.M., Sarrecchia, C., Angelico, M., Perno, C.F.

“…► Our study defined prevalence of drug-resistance in 140 drug-naïve patients. ► No YMDD mutations, rtM204V/I, were found. ► 1.4% of patients carried primary…”
Get full text

P0915 : Clinical relevance of baseline/early detection and persistence of resistant associated variants in HCV-1 patients treated with protease-inhibitors assessed by ultra-deep sequencing by Di Maio, V.C, Armenia, D, Bellocchi, M.C, Di Paolo, D, Cento, V, Tontodonati, M, Micheli, V, Carioti, L, De Leonardis, F, Aragri, M, Polilli, E, Manunta, A, Magni, C, Antonucci, F.P, De Luca, F, Sarrecchia, C, Bertoli, A, Lenci, I, Francioso, S, Santoro, M.M, Vecchiet, J, De Maria, A, Picciotto, A, Nosotti, L, Morisco, F, Bruno, S, Puoti, M, Babudieri, S, Mura, M.S, Taliani, G, Andreoni, M, Rizzardini, G, Parruti, G, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

P0903 : Slow HCV kinetics following sofosbuvir + ribavirin administration in real-life setting of liver transplant recipients with severe recurrent hepatitis C by Cento, V, Donato, M.F, Lenci, I, Rendina, M, Milana, M, Di Maio, V.C, Monico, S, Aragri, M, Alfieri, R, Abedrabbo, A, Sforza, D, Manuelli, M, Mameli, L, Sorbo, M.C, Canu, R, Ponti, M.L, Chialà, C, Malinverno, F, Marenco, S, Milanesi, L, Picciotto, A, Rossi, G, Di Leo, A, Tisone, G, Zamboni, F, Ganga, R, Colombo, M, Perno, C.F, Angelico, M, Ceccherini-Silberstein, F

Get full text

166 HCV DIVERSITY AND FIBROSIS PROGRESSION: NS5A AND CORE VARIANTS CORRELATE WITH SEVERITY OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION by Lenci, I, Cucchiarelli, S, Di Maio, V.C, Cento, V, De Luca, F, Milana, M, Antonucci, F.P, Di Paolo, D, Giardina, E, Tisone, G, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network by Cento, V, Barbaliscia, S, Di Maio, V.C, Masetti, C, Minichini, C, Magni, C.F, Micheli, V, Marenco, S, Nicolini, L.A, Bruzzone, B, Troshina, Y, Baiguera, C, Dentone, C, Calvaruso, V, Paolucci, S, Melis, M, Aragri, M, Bertoli, A, Lenci, I, Landonio, S, Schiavini, M, Sticchi, L, Ruggiero, T, Polilli, E, Messina, V, Pellicelli, A, Boglione, L, Cozzolongo, R, Biolato, M, Morisco, F, Siciliano, M, Parruti, G, Barbarini, G, Craxì, A, Babudieri, S, Puoti, M, Ciancio, A, Rizzardini, G, Coppola, N, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life by Cento, V, Barbaliscia, S, Lenci, I, Ruggiero, T, Masetti, C, Magni, C.F, Micheli, V, Paolucci, S, Troshina, Y, Biliotti, E, Milana, M, Melis, M, Teti, E, Lambiase, L, Menzaghi, B, Nicolini, L.A, Marenco, S, Di Maio, V.C, Aragri, M, Pecchioli, A, Bertoli, A, Antonucci, F.P, Sarmati, L, Sarrecchia, C, Macera, M, Coppola, N, Danieli, E, Romagnoli, D, Pellicelli, A, Bonora, S, Babudieri, S, Di Biagio, A, Picciotto, A, Novati, S, Siciliano, M, Messina, V, Claar, E, Baldanti, F, Pasquazzi, C, Ciancio, A, Puoti, M, Ghisetti, V, Andreoni, M, Taliani, G, Rizzardini, G, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

Natural HCV resistance is common in Italy and differently associated to genotypes by Sorbo, M.C, Cento, V, Bertoli, A, Lenci, I, Polilli, E, Masetti, C, Gianserra, L, Teti, E, Biliotti, E, Magni, C.F, Aragri, M, Micheli, V, Melis, M, Nicolini, L.A, Marenco, S, Calvaruso, V, Paolucci, S, Baldanti, F, Morisco, F, Siciliano, M, Pace Palitti, V, Andreone, P, Bruzzone, B, Coppola, N, Ruggiero, T, Lichtner, M, Menzaghi, B, Romagnoli, D, Iapadre, N, Di Maio, V.C, De Leonardis, F, Milana, M, Cacciatore, P, Pieri, A, Sarmati, L, Landonio, S, Gasbarrini, A, Puoti, M, Craxì, A, Vullo, V, Pellicelli, A, Babudieri, S, Rizzardini, G, Taliani, G, Andreoni, M, Pasquazzi, C, Parruti, G, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text